Latest News
- January 08, 2026Official press release: CBCC Global Research is now REV Clinical
- November 18, 2025ANDA application for Bimatoprost ophthalmic solution received Marketing Authorization from the USFDA!
- November 12, 2025ANDA application for Risperidone extended-release injectable suspension has received Marketing Authorization from the USFDA!
- October 30, 2025Accelerating Clinical Research!
- September 12, 2025Join CBCC at CPHI Frankfurt 2025
January 07, 2025
Accelerating Clinical Research!
Accelerating Clinical Research!
At CBCC, Our commitment to speed in clinical trials ensures rapid, reliable, and rigorous research outcomes. With seamless integration of global standards and local expertise, we accelerate every phase of the clinical research process to deliver timely results that meet the highest standards.
CBCC Global Research: CHANGING LIVES THROUGH HOPE AND INNOVATION
